DPI Research

The United States proton therapy market size was valued at USD 1 billion in 2024 and is projected to hit around USD 2.5 billion by 2033, growing at a CAGR of 12% during the forecast period 2025 to 2033.

The influenza vaccines market in the United States has experienced significant growth in recent years, driven by various factors, including heightened public awareness of infectious diseases and the ongoing innovations in vaccine technology.

The United States vaccine market was valued at around USD 29.5 billion in 2024 and is projected to reach around USD 60 billion by 2033, exhibiting a CAGR of 8 % during the forecast period.

United Arab Emirates Meetings, Incentives, Conferences, and Exhibitions tourism market is positioned for substantial growth. It was valued at US$ 1,977 million in 2023 and is expected to reach US$ 9,320 million by 2030, reflecting a CAGR of 24.8%.

The U.S. Self-Monitoring Blood Glucose Devices market size was accounted for at USD 4,045 million in 2023, and it is expected to reach around USD 7,138 million by 2032, poised to grow at a noteworthy CAGR of 6.5% during the forecast period

As per DPI Research latest published report, the China Non-Invasive Prenatal Testing (NIPT) market size was valued at US$ 608 million in 2023, and it is forecasted to reach US$ 1,083 million by the year-end of 2032.

The global diabetes insulin delivery pen market size was valued at USD 17.7 Billion in 2023 and is likely to reach USD 28.7 Billion in 2032, expanding at a CAGR 5.5% during the forecast period.

The global influenza vaccine market size was valued at USD 7.8 billion in 2023 and is likely to reach USD 13.7 billion in 2032, expanding at a CAGR of 7.2% during the forecast period.

United Arab Emirates Meetings, Incentives, Conferences, and Exhibitions tourism market is positioned for substantial growth. It was valued at US$ 1,977 million in 2023 and is expected to reach US$ 9,320 million by 2030, reflecting a CAGR of 24.8%.

Tracks recent competitive developments, approaches, recent industry developments, mergers & acquisitions, collaboration deals, partnership deals, distribution, exclusive, and licensing agreement